Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New ingol-type diterpenes from the latex of Euphorbia resinifera.
Wang SY, Li GY, Zhang K, Wang HY, Liang HG, Huang C, Huang J, Wang JH, Yang BF. Wang SY, et al. Among authors: liang hg. J Asian Nat Prod Res. 2019 Nov;21(11):1075-1082. doi: 10.1080/10286020.2018.1498084. Epub 2019 Jan 4. J Asian Nat Prod Res. 2019. PMID: 30607997
Three new sesquiterpenes from Pterocarpus santalinus.
Li L, Tao RH, Wu JM, Guo YP, Huang C, Liang HG, Fan LZ, Zhang HY, Sun RK, Shang L, Lu LN, Huang J, Wang JH. Li L, et al. Among authors: liang hg. J Asian Nat Prod Res. 2018 Apr;20(4):306-312. doi: 10.1080/10286020.2017.1335714. Epub 2017 Jun 5. J Asian Nat Prod Res. 2018. PMID: 28581822
[Triterpenoids from Uygur medicine latex of Euphorbia resinifera].
Wang SY, Li GY, Zhang K, Wang HY, Liang HG, Huang C, Huang J, Wang JH, Yang BF. Wang SY, et al. Among authors: liang hg. Zhongguo Zhong Yao Za Zhi. 2018 Sep;43(18):3688-3693. doi: 10.19540/j.cnki.cjcmm.20180625.003. Zhongguo Zhong Yao Za Zhi. 2018. PMID: 30384534 Chinese.
New triterpenoids from the latex of Euphorbia resinifera Berg.
Wang S, Liang H, Zhao Y, Wang G, Yao H, Kasimu R, Wu Z, Li Y, Huang J, Wang J. Wang S, et al. Fitoterapia. 2016 Jan;108:33-40. doi: 10.1016/j.fitote.2015.11.009. Epub 2015 Nov 14. Fitoterapia. 2016. PMID: 26586618
Icotinib, an EGFR tyrosine kinase inhibitor, as adjuvant therapy for patients with stage IIA-IIIA EGFR-mutant non-small-cell lung adenocarcinoma: a multicenter, open-label, single-arm, phase II study (ICAPE).
Qian K, Chen QR, He M, Wang ZT, Liu Y, Liang HG, Su ZY, Cui YS, Liu LJ, Zhang Y. Qian K, et al. Among authors: liang hg. Invest New Drugs. 2023 Feb;41(1):44-52. doi: 10.1007/s10637-022-01316-5. Epub 2022 Nov 10. Invest New Drugs. 2023. PMID: 36355317 Clinical Trial.
37 results